← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2016Last known activity
Aug 1, 2016
Timeline
No events for the selected filters.
Drugs by trial phase (1 distinct, 1 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT02787083Reponsible party - principal investigatorPhase 3Aug 1, 2016
- NCT02787083Study directorPhase 3Aug 1, 2016
- NCT02787083Lead sponsorPhase 3Aug 1, 2016
Details
- Last known activity
- Aug 1, 2016